Table 1.
Associations between miR-125 expression and clinicopathological characteristics
| Characteristics | n = 58 | miR-125 | P value | |
|---|---|---|---|---|
| High (n = 28) | Low (n = 30) | |||
| Age (years) | 0.621 | |||
| ≥ 45 | 33 | 15 | 18 | |
| < 45 | 25 | 13 | 12 | |
| HPV 16/18 infection | 0.301 | |||
| Positive | 41 | 18 | 23 | |
| Negative | 17 | 10 | 7 | |
| Tumor size | 0.031* | |||
| < 4 cm | 25 | 8 | 17 | |
| ≥ 4 cm | 33 | 20 | 13 | |
| Histology | 0.397 | |||
| Squamous cell cancer | 24 | 10 | 14 | |
| Adenocarcinima and others | 34 | 18 | 16 | |
| Differentiation | 0.061 | |||
| Well and moderately | 40 | 16 | 24 | |
| Poor | 18 | 12 | 6 | |
| FIGO | 0.018* | |||
| I | 36 | 13 | 23 | |
| II | 22 | 15 | 7 | |
| Lymph node metastasis | 0.923 | |||
| Negative | 39 | 19 | 20 | |
| Positive | 19 | 9 | 10 | |
Statistical analyses were performed by the χ2 test
*P < 0.05 was considered significant